{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:29:21Z","timestamp":1792441761657,"version":"4.5.0"},"reference-count":61,"publisher":"National Institute for Health and Care Research","issue":"38","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["11\/36\/29"],"award-info":[{"award-number":["11\/36\/29"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Management of bone and joint infection commonly includes 4\u20136 weeks of intravenous (IV) antibiotics, but there is little evidence to suggest that oral (PO) therapy results in worse outcomes.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether or not PO antibiotics are non-inferior to IV antibiotics in treating bone and joint infection.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Parallel-group, randomised (1\u2009:\u20091), open-label, non-inferiority trial. The non-inferiority margin was 7.5%.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Twenty-six NHS hospitals.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Adults with a clinical diagnosis of bone, joint or orthopaedic metalware-associated infection who would ordinarily receive at least 6 weeks of antibiotics, and who had received \u2264\u20097 days of IV therapy from definitive surgery (or start of planned curative treatment in patients managed non-operatively).<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were centrally computer-randomised to PO or IV antibiotics to complete the first 6 weeks of therapy. Follow-on PO therapy was permitted in either arm.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measure<\/jats:title>\n The primary outcome was the proportion of participants experiencing treatment failure within 1 year. An associated cost-effectiveness evaluation assessed health resource use and quality-of-life data.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Out of 1054 participants (527 in each arm), end-point data were available for 1015 (96.30%) participants. Treatment failure was identified in 141 out of 1015 (13.89%) participants: 74 out of 506 (14.62%) and 67 out of 509 (13.16%) of those participants randomised to IV and PO therapy, respectively. In the intention-to-treat analysis, using multiple imputation to include all participants, the imputed risk difference between PO and IV therapy for definitive treatment failure was \u20131.38% (90% confidence interval \u20134.94% to 2.19%), thus meeting the non-inferiority criterion. A complete-case analysis, a per-protocol analysis and sensitivity analyses for missing data each confirmed this result. With the exception of IV catheter complications [49\/523 (9.37%) in the IV arm vs. 5\/523 (0.96%) in the PO arm)], there was no significant difference between the two arms in the incidence of serious adverse events. PO therapy was highly cost-effective, yielding a saving of \u00a32740 per patient without any significant difference in quality-adjusted life-years between the two arms of the trial.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n The OVIVA (Oral Versus IntraVenous Antibiotics) trial was an open-label trial, but bias was limited by assessing all potential end points by a blinded adjudication committee. The population was heterogenous, which facilitated generalisability but limited the statistical power of subgroup analyses. Participants were only followed up for 1 year so differences in late recurrence cannot be excluded.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n PO antibiotic therapy is non-inferior to IV therapy when used during the first 6 weeks in the treatment for bone and joint infection, as assessed by definitive treatment failure within 1 year of randomisation. These findings challenge the current standard of care and provide an opportunity to realise significant benefits for patients, antimicrobial stewardship and the health economy.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n Further work is required to define the optimal total duration of therapy for bone and joint infection in the context of specific surgical interventions. Currently, wide variation in clinical practice suggests significant redundancy that likely contributes to the excess and unnecessary use of antibiotics.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Current Controlled Trials ISRCTN91566927.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 23, No. 38. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta23380","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:02:17Z","timestamp":1564743737000},"page":"1-92","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT"],"prefix":"10.3310","volume":"23","clinical-trial-number":[{"clinical-trial-number":"isrctn91566927","registry":"10.18810\/isrctn","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0455-0785","authenticated-orcid":true,"given":"Matthew","family":"Scarborough","sequence":"first","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8149-5943","authenticated-orcid":true,"given":"Ho Kwong","family":"Li","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"},{"name":"Division of Infectious Diseases, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3464-3867","authenticated-orcid":true,"given":"Ines","family":"Rombach","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0909-2920","authenticated-orcid":true,"given":"Rhea","family":"Zambellas","sequence":"additional","affiliation":[{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-8509","authenticated-orcid":true,"given":"A Sarah","family":"Walker","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit, University College London, London, UK"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-9044","authenticated-orcid":true,"given":"Martin","family":"McNally","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-0633","authenticated-orcid":true,"given":"Bridget","family":"Atkins","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4618-6528","authenticated-orcid":true,"given":"Michelle","family":"K\u00fcmin","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-5114","authenticated-orcid":true,"given":"Benjamin A","family":"Lipsky","sequence":"additional","affiliation":[{"name":"Green Templeton College, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-0731","authenticated-orcid":true,"given":"Harriet","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Public Health, University Hospital of Wales, Public Health Wales, Cardiff, Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-2438","authenticated-orcid":true,"given":"Deepa","family":"Bose","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-6303","authenticated-orcid":true,"given":"Simon","family":"Warren","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Microbiology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK"},{"name":"Infectious Diseases and Microbiology, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-6467","authenticated-orcid":true,"given":"Damien","family":"Mack","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Microbiology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK"},{"name":"Infectious Diseases and Microbiology, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-7118","authenticated-orcid":true,"given":"Jonathan","family":"Folb","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Moore","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Microbiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-5709","authenticated-orcid":true,"given":"Neil","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Heart of England NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5179-5702","authenticated-orcid":true,"given":"Susan","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Microbiology, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-0597","authenticated-orcid":true,"given":"R Andrew","family":"Seaton","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Microbiology, Gartnaval General Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0558-3984","authenticated-orcid":true,"given":"Carolyn","family":"Hemsley","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0193-8677","authenticated-orcid":true,"given":"Jonathan","family":"Sandoe","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-2411","authenticated-orcid":true,"given":"Ila","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Diseases, Ninewells Hospital, NHS Tayside, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-3818","authenticated-orcid":true,"given":"Simon","family":"Ellis","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Northumbria Healthcare NHS Foundation Trust, Cramlington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5214-9630","authenticated-orcid":true,"given":"Rebecca","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Regional Infectious Diseases Unit, Western General Hospital, NHS Lothian, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2243-0733","authenticated-orcid":true,"given":"Claudia","family":"Geue","sequence":"additional","affiliation":[{"name":"Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-8820","authenticated-orcid":true,"given":"Nicola","family":"McMeekin","sequence":"additional","affiliation":[{"name":"Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4390-3598","authenticated-orcid":true,"given":"Claire","family":"Scarborough","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-9153","authenticated-orcid":true,"given":"John","family":"Paul","sequence":"additional","affiliation":[{"name":"National Infection Service, Public Health England, Horsham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6475-5056","authenticated-orcid":true,"given":"Graham","family":"Cooke","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-9350","authenticated-orcid":true,"given":"Jennifer","family":"Bostock","sequence":"additional","affiliation":[{"name":"Patient and Public Representative, Division of Health and Social Care Research, King\u2019s College London, , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-1340","authenticated-orcid":true,"given":"Elham","family":"Khatamzas","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6325-8821","authenticated-orcid":true,"given":"Nick","family":"Wong","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0723","authenticated-orcid":true,"given":"Andrew","family":"Brent","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8092-805X","authenticated-orcid":true,"given":"Jose","family":"Lomas","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":true,"given":"Philippa","family":"Matthews","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"},{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-5699","authenticated-orcid":true,"given":"Tri","family":"Wangrangsimakul","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-8853","authenticated-orcid":true,"given":"Roger","family":"Gundle","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5858-2088","authenticated-orcid":true,"given":"Mark","family":"Rogers","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7521-8643","authenticated-orcid":true,"given":"Adrian","family":"Taylor","sequence":"additional","affiliation":[{"name":"Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2858-2087","authenticated-orcid":true,"given":"Guy E","family":"Thwaites","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-7549","authenticated-orcid":true,"given":"Philip","family":"Bejon","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2019,8]]},"reference":[{"key":"key20190801131835215_ref1-bib1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s13063-015-1098-y","article-title":"Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial","volume":"16","author":"Li","year":"2015","journal-title":"Trials"},{"key":"key20190801131835215_ref1-bib2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"key20190801131835215_ref1-bib3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s15010-002-3079-9","article-title":"Management of infection associated with prosthetic joints","volume":"31","author":"Zimmerli","year":"2003","journal-title":"Infection"},{"key":"key20190801131835215_ref1-bib4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1297-319X(01)00315-3","article-title":"Management of nontuberculous infectious discitis. Treatments used in 110 patients admitted to 12 teaching hospitals in France","volume":"68","author":"Legrand","year":"2001","journal-title":"Joint Bone Spine"},{"key":"key20190801131835215_ref1-bib5","first-page":"31","article-title":"Out-patient parenteral antibiotic therapy (OPAT): clinical outcomes and adverse events","volume":"60","author":"Berman","year":"2001","journal-title":"Hawaii Med J"},{"key":"key20190801131835215_ref1-bib6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/jac\/dkm210","article-title":"Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years","volume":"60","author":"Matthews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key20190801131835215_ref1-bib7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000048562","article-title":"Outpatient parenteral antimicrobial therapy (OPAT): a global perspective. Introduction","volume":"47","author":"Tice","year":"2001","journal-title":"Chemotherapy"},{"key":"key20190801131835215_ref1-bib8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijantimicag.2008.07.016","article-title":"A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective","volume":"33","author":"Yong","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key20190801131835215_ref1-bib9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0002-9343(93)90134-B","article-title":"Home intravenous antibiotic therapy","volume":"94","author":"Tice","year":"1993","journal-title":"Am J Med"},{"key":"key20190801131835215_ref1-bib10","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","article-title":"Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial","volume":"333","author":"Oosterheert","year":"2006","journal-title":"BMJ"},{"key":"key20190801131835215_ref1-bib11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/bmj.39244.692442.55","article-title":"Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial","volume":"335","author":"Montini","year":"2007","journal-title":"BMJ"},{"key":"key20190801131835215_ref1-bib12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1086\/317552","article-title":"Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer","volume":"32","author":"Shenep","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key20190801131835215_ref1-bib13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key20190801131835215_ref1-bib14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomised comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"key":"key20190801131835215_ref1-bib15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004439.pub2","article-title":"Antibiotics for treating chronic osteomyelitis in adults","volume":"3","author":"Conterno","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20190801131835215_ref1-bib16","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1128\/AAC.01504-08","article-title":"Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key20190801131835215_ref1-bib17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1302\/0301-620X.91B1.20930","article-title":"Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection?","volume":"91","author":"Whittaker","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"key20190801131835215_ref1-bib18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1302\/0301-620X.88B8.17445","article-title":"Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy","volume":"88","author":"Hart","year":"2006","journal-title":"J Bone Joint Surg Br"},{"key":"key20190801131835215_ref1-bib19","first-page":"400","article-title":"Risks and complications of prolonged parenteral antibiotic treatment in children with acute osteoarticular infections","volume":"69","author":"Ceroni","year":"2003","journal-title":"Acta Orthop Belg"},{"key":"key20190801131835215_ref1-bib20","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","article-title":"Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections","volume":"15","author":"Nguyen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key20190801131835215_ref1-bib21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jinf.2006.11.011","article-title":"Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis","volume":"54","author":"Daver","year":"2007","journal-title":"J Infect"},{"key":"key20190801131835215_ref1-bib22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"key20190801131835215_ref1-bib23","first-page":"325","article-title":"Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia","volume":"26","author":"Diaz","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"key20190801131835215_ref1-bib24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00126334-200306010-00016","article-title":"Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping","volume":"33","author":"Farley","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20190801131835215_ref1-bib25","unstructured":"European Commission. Directive 2001\/20\/EC of the European Parliament and of the Council of 4 April 2001. Brussels: European Commission; 2001."},{"key":"key20190801131835215_ref1-bib26","unstructured":"Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. URL: www.medicinescomplete.com (accessed 12 December 2016)."},{"key":"key20190801131835215_ref1-bib27","unstructured":"Department of Health and Social Care. NHS Reference Costs 2014 to 2015. London: Department of Health and Social Care; 2016."},{"key":"key20190801131835215_ref1-bib28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/bjc.2016.76","article-title":"Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation","volume":"114","author":"Wu","year":"2016","journal-title":"Br J Cancer"},{"key":"key20190801131835215_ref1-bib29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.12688\/wellcomeopenres.15314.1","article-title":"Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial [version 1; peer review: awaiting peer review]","volume":"4","author":"McMeekin","year":"2019","journal-title":"Wellcome Open Res"},{"key":"key20190801131835215_ref1-bib30","volume-title":"Unit Costs of Health and Social Care 2015","author":"Curtis","year":"2015"},{"key":"key20190801131835215_ref1-bib31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol G","year":"1990","journal-title":"Health Pol"},{"key":"key20190801131835215_ref1-bib32","volume-title":"EuroQol \u2013 About EQ-5D","author":"EuroQol","year":"2017"},{"key":"key20190801131835215_ref1-bib33","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"key20190801131835215_ref1-bib34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","article-title":"Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report","volume":"18","author":"Ramsey","year":"2015","journal-title":"Value Health"},{"key":"key20190801131835215_ref1-bib35","unstructured":"NICE. Guide to the Methods of Technology Appraisal: 2013. London: NICE. URL: www.nice.org.uk\/article\/pmg9\/chapter\/foreword (accessed 13 September 2017)."},{"key":"key20190801131835215_ref1-bib36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hec.766","article-title":"Missing.... presumed at random: cost-analysis of incomplete data","volume":"12","author":"Briggs","year":"2003","journal-title":"Health Econ"},{"key":"key20190801131835215_ref1-bib37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"PharmacoEconomics"},{"key":"key20190801131835215_ref1-bib38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1056\/NEJM197001222820406","article-title":"Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects","volume":"282","author":"Waldvogel","year":"1970","journal-title":"N Engl J Med"},{"key":"key20190801131835215_ref1-bib39","first-page":"3788","volume-title":"Oxford Textbook of Medicine","author":"Berendt","year":"2010","edition":"5th edn."},{"key":"key20190801131835215_ref1-bib40","first-page":"1039","volume-title":"Principles and Practice of Infectious Diseases","author":"Mader","year":"1995","edition":"4th edn."},{"key":"key20190801131835215_ref1-bib41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.diagmicrobio.2009.08.016","article-title":"Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey","volume":"66","author":"Johannsson","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20190801131835215_ref1-bib42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"key20190801131835215_ref1-bib43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5694\/mja12.11703","article-title":"Determining research priorities for clinician-initiated trials in infectious diseases","volume":"198","author":"Paterson","year":"2013","journal-title":"Med J Aust"},{"key":"key20190801131835215_ref1-bib44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1086\/501639","article-title":"Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study","volume":"20","author":"Soufir","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key20190801131835215_ref1-bib45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1302\/0301-620X.78B2.0780185","article-title":"Questionnaire on the perceptions of patients about total hip replacement","volume":"78","author":"Dawson","year":"1996","journal-title":"J Bone Joint Surg Br"},{"key":"key20190801131835215_ref1-bib46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1302\/0301-620X.80B1.7859","article-title":"Questionnaire on the perceptions of patients about total knee replacement","volume":"80","author":"Dawson","year":"1998","journal-title":"J Bone Joint Surg Br"},{"key":"key20190801131835215_ref1-bib47","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/jac\/dkp107","article-title":"One hundred and twelve infected arthroplasties treated with \u2018DAIR\u2019 (debridement, antibiotics and implant retention): antibiotic duration and outcome","volume":"63","author":"Byren","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key20190801131835215_ref1-bib48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/1874325001307010227","article-title":"Economical analysis on prophylaxis, diagnosis, and treatment of periprosthetic infections","volume":"7","author":"Fernandez-Fairen","year":"2013","journal-title":"Open Orthop J"},{"key":"key20190801131835215_ref1-bib49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1086\/318502","article-title":"Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly","volume":"32","author":"Fisman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key20190801131835215_ref1-bib50","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.arth.2013.02.026","article-title":"Economic evaluation of chlorhexidine cloths on healthcare costs due to surgical site infections following total knee arthroplasty","volume":"28","author":"Kapadia","year":"2013","journal-title":"J Arthroplasty"},{"key":"key20190801131835215_ref1-bib51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1302\/0301-620X.94B5.27073","article-title":"A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff","volume":"94","author":"Vanhegan","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"key20190801131835215_ref1-bib52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1302\/0301-620X.97B2.33707","article-title":"Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service?","volume":"97\u2013B","author":"Kallala","year":"2015","journal-title":"Bone Joint J"},{"key":"key20190801131835215_ref1-bib53","doi-asserted-by":"publisher","first-page":"821650","DOI":"10.1155\/2013\/821650","article-title":"Treatment of periprosthetic infections: an economic analysis","volume":"2013","author":"Hern\u00e1ndez-Vaquero","year":"2013","journal-title":"Sci World J"},{"key":"key20190801131835215_ref1-bib54","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/514991","article-title":"Risk factors for prosthetic joint infection: case-control study","volume":"27","author":"Berbari","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key20190801131835215_ref1-bib55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cis966","article-title":"Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key20190801131835215_ref1-bib56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1055\/s-0029-1214161","article-title":"Systemic antimicrobial therapy in osteomyelitis","volume":"23","author":"Fraimow","year":"2009","journal-title":"Semin Plast Surg"},{"key":"key20190801131835215_ref1-bib57","volume-title":"Homecare Medicines \u2018Towards a Vision for the Future\u2019","author":"Hackett"},{"key":"key20190801131835215_ref1-bib58","volume-title":"The Community IntraVenous Antibiotic Study (CIVAS): A Mixed-methods Evaluation of Patient Preferences for and Cost-effectiveness of Different Service Models for Delivering Outpatient Parenteral Antimicrobial Therapy","author":"Minton","year":"2017"},{"key":"key20190801131835215_ref1-bib59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key20190801131835215_ref1-bib60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00192-016-2952-5","article-title":"Erratum to: Rectocutaneous fistula with transmigration of the suture: a rare delayed complication of vault fixation with the sacrospinous ligament","volume":"27","author":"Kadam","year":"2016","journal-title":"Int Urogynecol J"},{"key":"key20190801131835215_ref1-bib61","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/01.ccm.0000509756.02057.eb","article-title":"1081: comparing complication rates in central lines versus peripherally inserted central catheters","volume":"44","author":"Noonan","year":"2016","journal-title":"Crit Care Med"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta23380\/hta23380.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2009559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta23380\/hta23380.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2029807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:47:37Z","timestamp":1692114457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta23380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":61,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["10.3310\/hta23380"],"URL":"https:\/\/doi.org\/10.3310\/hta23380","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}